2023-2028 Global and Regional Polio (Poliomyelitis) Vaccines Industry Status and Prospects Professional Market Research Report Standard Version

  • Report Code : 1002501
  • Industry : Chemicals and Materials
  • Published On : Sep 2023
  • Pages : 146
  • Publisher : HNY Research
  • Format: WMR PPT FormatWMR PDF Format

The global Polio (Poliomyelitis) Vaccines market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

By Market Verdors:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

By Types:
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)

By Applications:
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Polio (Poliomyelitis) Vaccines Market Size Analysis from 2023 to 2028
1.5.1 Global Polio (Poliomyelitis) Vaccines Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Polio (Poliomyelitis) Vaccines Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Polio (Poliomyelitis) Vaccines Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Polio (Poliomyelitis) Vaccines Industry Impact
Chapter 2 Global Polio (Poliomyelitis) Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Polio (Poliomyelitis) Vaccines (Volume and Value) by Type
2.1.1 Global Polio (Poliomyelitis) Vaccines Consumption and Market Share by Type (2017-2022)
2.1.2 Global Polio (Poliomyelitis) Vaccines Revenue and Market Share by Type (2017-2022)
2.2 Global Polio (Poliomyelitis) Vaccines (Volume and Value) by Application
2.2.1 Global Polio (Poliomyelitis) Vaccines Consumption and Market Share by Application (2017-2022)
2.2.2 Global Polio (Poliomyelitis) Vaccines Revenue and Market Share by Application (2017-2022)
2.3 Global Polio (Poliomyelitis) Vaccines (Volume and Value) by Regions
2.3.1 Global Polio (Poliomyelitis) Vaccines Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Polio (Poliomyelitis) Vaccines Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Polio (Poliomyelitis) Vaccines Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Polio (Poliomyelitis) Vaccines Consumption by Regions (2017-2022)
4.2 North America Polio (Poliomyelitis) Vaccines Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Polio (Poliomyelitis) Vaccines Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Polio (Poliomyelitis) Vaccines Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Polio (Poliomyelitis) Vaccines Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Polio (Poliomyelitis) Vaccines Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Polio (Poliomyelitis) Vaccines Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Polio (Poliomyelitis) Vaccines Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Polio (Poliomyelitis) Vaccines Sales, Consumption, Export, Import (2017-2022)
4.10 South America Polio (Poliomyelitis) Vaccines Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Polio (Poliomyelitis) Vaccines Market Analysis
5.1 North America Polio (Poliomyelitis) Vaccines Consumption and Value Analysis
5.1.1 North America Polio (Poliomyelitis) Vaccines Market Under COVID-19
5.2 North America Polio (Poliomyelitis) Vaccines Consumption Volume by Types
5.3 North America Polio (Poliomyelitis) Vaccines Consumption Structure by Application
5.4 North America Polio (Poliomyelitis) Vaccines Consumption by Top Countries
5.4.1 United States Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
5.4.2 Canada Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
5.4.3 Mexico Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
Chapter 6 East Asia Polio (Poliomyelitis) Vaccines Market Analysis
6.1 East Asia Polio (Poliomyelitis) Vaccines Consumption and Value Analysis
6.1.1 East Asia Polio (Poliomyelitis) Vaccines Market Under COVID-19
6.2 East Asia Polio (Poliomyelitis) Vaccines Consumption Volume by Types
6.3 East Asia Polio (Poliomyelitis) Vaccines Consumption Structure by Application
6.4 East Asia Polio (Poliomyelitis) Vaccines Consumption by Top Countries
6.4.1 China Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
6.4.2 Japan Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
6.4.3 South Korea Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
Chapter 7 Europe Polio (Poliomyelitis) Vaccines Market Analysis
7.1 Europe Polio (Poliomyelitis) Vaccines Consumption and Value Analysis
7.1.1 Europe Polio (Poliomyelitis) Vaccines Market Under COVID-19
7.2 Europe Polio (Poliomyelitis) Vaccines Consumption Volume by Types
7.3 Europe Polio (Poliomyelitis) Vaccines Consumption Structure by Application
7.4 Europe Polio (Poliomyelitis) Vaccines Consumption by Top Countries
7.4.1 Germany Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
7.4.2 UK Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
7.4.3 France Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
7.4.4 Italy Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
7.4.5 Russia Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
7.4.6 Spain Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
7.4.7 Netherlands Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
7.4.8 Switzerland Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
7.4.9 Poland Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
Chapter 8 South Asia Polio (Poliomyelitis) Vaccines Market Analysis
8.1 South Asia Polio (Poliomyelitis) Vaccines Consumption and Value Analysis
8.1.1 South Asia Polio (Poliomyelitis) Vaccines Market Under COVID-19
8.2 South Asia Polio (Poliomyelitis) Vaccines Consumption Volume by Types
8.3 South Asia Polio (Poliomyelitis) Vaccines Consumption Structure by Application
8.4 South Asia Polio (Poliomyelitis) Vaccines Consumption by Top Countries
8.4.1 India Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
8.4.2 Pakistan Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Polio (Poliomyelitis) Vaccines Market Analysis
9.1 Southeast Asia Polio (Poliomyelitis) Vaccines Consumption and Value Analysis
9.1.1 Southeast Asia Polio (Poliomyelitis) Vaccines Market Under COVID-19
9.2 Southeast Asia Polio (Poliomyelitis) Vaccines Consumption Volume by Types
9.3 Southeast Asia Polio (Poliomyelitis) Vaccines Consumption Structure by Application
9.4 Southeast Asia Polio (Poliomyelitis) Vaccines Consumption by Top Countries
9.4.1 Indonesia Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
9.4.2 Thailand Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
9.4.3 Singapore Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
9.4.4 Malaysia Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
9.4.5 Philippines Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
9.4.6 Vietnam Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
9.4.7 Myanmar Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
Chapter 10 Middle East Polio (Poliomyelitis) Vaccines Market Analysis
10.1 Middle East Polio (Poliomyelitis) Vaccines Consumption and Value Analysis
10.1.1 Middle East Polio (Poliomyelitis) Vaccines Market Under COVID-19
10.2 Middle East Polio (Poliomyelitis) Vaccines Consumption Volume by Types
10.3 Middle East Polio (Poliomyelitis) Vaccines Consumption Structure by Application
10.4 Middle East Polio (Poliomyelitis) Vaccines Consumption by Top Countries
10.4.1 Turkey Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
10.4.3 Iran Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
10.4.5 Israel Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
10.4.6 Iraq Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
10.4.7 Qatar Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
10.4.8 Kuwait Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
10.4.9 Oman Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
Chapter 11 Africa Polio (Poliomyelitis) Vaccines Market Analysis
11.1 Africa Polio (Poliomyelitis) Vaccines Consumption and Value Analysis
11.1.1 Africa Polio (Poliomyelitis) Vaccines Market Under COVID-19
11.2 Africa Polio (Poliomyelitis) Vaccines Consumption Volume by Types
11.3 Africa Polio (Poliomyelitis) Vaccines Consumption Structure by Application
11.4 Africa Polio (Poliomyelitis) Vaccines Consumption by Top Countries
11.4.1 Nigeria Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
11.4.2 South Africa Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
11.4.3 Egypt Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
11.4.4 Algeria Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
11.4.5 Morocco Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
Chapter 12 Oceania Polio (Poliomyelitis) Vaccines Market Analysis
12.1 Oceania Polio (Poliomyelitis) Vaccines Consumption and Value Analysis
12.2 Oceania Polio (Poliomyelitis) Vaccines Consumption Volume by Types
12.3 Oceania Polio (Poliomyelitis) Vaccines Consumption Structure by Application
12.4 Oceania Polio (Poliomyelitis) Vaccines Consumption by Top Countries
12.4.1 Australia Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
12.4.2 New Zealand Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
Chapter 13 South America Polio (Poliomyelitis) Vaccines Market Analysis
13.1 South America Polio (Poliomyelitis) Vaccines Consumption and Value Analysis
13.1.1 South America Polio (Poliomyelitis) Vaccines Market Under COVID-19
13.2 South America Polio (Poliomyelitis) Vaccines Consumption Volume by Types
13.3 South America Polio (Poliomyelitis) Vaccines Consumption Structure by Application
13.4 South America Polio (Poliomyelitis) Vaccines Consumption Volume by Major Countries
13.4.1 Brazil Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
13.4.2 Argentina Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
13.4.3 Columbia Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
13.4.4 Chile Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
13.4.5 Venezuela Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
13.4.6 Peru Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
13.4.8 Ecuador Polio (Poliomyelitis) Vaccines Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Polio (Poliomyelitis) Vaccines Business
14.1 Sanofi
14.1.1 Sanofi Company Profile
14.1.2 Sanofi Polio (Poliomyelitis) Vaccines Product Specification
14.1.3 Sanofi Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 GSK
14.2.1 GSK Company Profile
14.2.2 GSK Polio (Poliomyelitis) Vaccines Product Specification
14.2.3 GSK Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Bibcol
14.3.1 Bibcol Company Profile
14.3.2 Bibcol Polio (Poliomyelitis) Vaccines Product Specification
14.3.3 Bibcol Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Serum Institute
14.4.1 Serum Institute Company Profile
14.4.2 Serum Institute Polio (Poliomyelitis) Vaccines Product Specification
14.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Tiantan Biological
14.5.1 Tiantan Biological Company Profile
14.5.2 Tiantan Biological Polio (Poliomyelitis) Vaccines Product Specification
14.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 IMBCA
14.6.1 IMBCA Company Profile
14.6.2 IMBCA Polio (Poliomyelitis) Vaccines Product Specification
14.6.3 IMBCA Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Panacea Biotec Ltd
14.7.1 Panacea Biotec Ltd Company Profile
14.7.2 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product Specification
14.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Bio-Med
14.8.1 Bio-Med Company Profile
14.8.2 Bio-Med Polio (Poliomyelitis) Vaccines Product Specification
14.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Halfkin Bio-Pharmaceuticals
14.9.1 Halfkin Bio-Pharmaceuticals Company Profile
14.9.2 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product Specification
14.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Polio (Poliomyelitis) Vaccines Market Forecast (2023-2028)
15.1 Global Polio (Poliomyelitis) Vaccines Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Polio (Poliomyelitis) Vaccines Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Polio (Poliomyelitis) Vaccines Value and Growth Rate Forecast (2023-2028)
15.2 Global Polio (Poliomyelitis) Vaccines Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Polio (Poliomyelitis) Vaccines Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Polio (Poliomyelitis) Vaccines Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Polio (Poliomyelitis) Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Polio (Poliomyelitis) Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Polio (Poliomyelitis) Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Polio (Poliomyelitis) Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Polio (Poliomyelitis) Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Polio (Poliomyelitis) Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Polio (Poliomyelitis) Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Polio (Poliomyelitis) Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Polio (Poliomyelitis) Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Polio (Poliomyelitis) Vaccines Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Polio (Poliomyelitis) Vaccines Consumption Forecast by Type (2023-2028)
15.3.2 Global Polio (Poliomyelitis) Vaccines Revenue Forecast by Type (2023-2028)
15.3.3 Global Polio (Poliomyelitis) Vaccines Price Forecast by Type (2023-2028)
15.4 Global Polio (Poliomyelitis) Vaccines Consumption Volume Forecast by Application (2023-2028)
15.5 Polio (Poliomyelitis) Vaccines Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (thousand ton / metric ton / cubic meter).
Market is segmented by:
  • Product Types
  • Applications
  • Technology
  • End-use Industries
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers and restraints
  • Regulatory scenario
  • Industry trend
  • Pestle analysis
  • Porter’s analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved